Skip to main content

Akebia Therapeutics, Inc 10-K for FY2024

Akebia Therapeutics, Inc. (AKBA)

10-K 2025-03-13 For: 2024-12-31
View Original
Added on April 11, 2026

About this 10-K

Akebia Therapeutics, Inc filed this 10-K on March 13, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$160.18M
down 17.7% from $194.62M a year earlier
Net loss
$69.41M
compared with a net loss of $51.93M a year earlier
Diluted EPS
-$0.33
compared with -$0.28 a year earlier